Dr. Alessandra Borba present new results of AMAZONA III study at San Antonio Breast Cancer Symposium 2019

Dr. Alessandra Borba present new results of AMAZONA III study at San Antonio Breast Cancer Symposium 2019, US. The poster entitled “Prevalence of patients with genetic testing indication for Hereditary Breast and Ovarian Syndrome (HBOC) in the Brazilian cohort study” showed that 37% of patients diagnosed with breast cancer have a criteria for HBOC syndrome criteria and only 6.9% of patients were tested for BRCA mutation. This study highlights the limited access to genetic counselling and BRCA test in Brazil, specially in the publica health system.